SHANDONG SHENGTAI BIOTECHNOLOGY CO., LTD

About us

The group has more than 10 wholly-owned or holding subsidiaries, including Weifang Shengtai Medicine, Shengtai Biotechnology, Weifang Century-light Biology Science, Fuyun Oils, Shengtai Trading and Weifang Chengli Zhonghe. The group's core business includes five major sectors: pharmaceutical raw materials and auxiliary materials, food raw and auxiliary materials, food additives, edible oil, and commercial logistics. The group is committed to providing customers with one-stop solutions from new product research and development, production and manufacturing to sales services. The group currently has total assets of 3 billion yuan, more than 1100 employees, and an annual total operating income of 5 billion yuan. Weifang Shengtai Pharmaceutical Co., Ltd. is the core enterprise of Shengtai Group, established in February 1999. The total assets are 2 billion yuan and there are 760 employees. Mainly engaged in the research and development, manufacturing, and sales of raw materials and pharmaceutical excipients such as starch and glucose, with an annual production of 500000 tons of starch series products and 300000 tons of glucose series products. The product is widely used in industries such as medicine, food, papermaking, fine chemicals, and biotechnology, and is sold to 30 provinces, municipalities, and autonomous regions in China, and exported to more than 70 countries and regions. Among them, medicinal grade glucose is a "famous brand" product in Shandong Province, with a domestic market share of over 60%. Has been awarded honors such as "Key Leading Enterprise in Agricultural Industrialization" and "Invisible Champion Enterprise" in Shandong Province, "Top 100 Industrial Enterprises", "Top 50 Agricultural Leading Enterprises", and "Intelligent Manufacturing Benchmark Enterprise" in Weifang City. The Group adheres to the innovation-driven development strategy. In recent years, it has focused on increasing the independent research and development, promotion and application of new products, technologies, and processes in industry segments, and continuously enhancing its core competitiveness. There are currently 3 provincial-level R&D platforms and 4 municipal level R&D platforms, with multiple laboratories and pilot workshops under them. Various experimental instruments and equipment are well-equipped, with a research and development team of over 50 people and an analysis and testing team of nearly 100 people, effectively promoting technological innovation and high-quality development of the enterprise.

Specs about this supplier